2010 Annual Meeting

Session: Nanomedicine and Drug Delivery IV

Advances in nanotechnology hold significant promise to play vital roles in the diagnostic and treatment of human disease. This session is focused on advances of nanotechnology for drug delivery applications.

Chair

Hamid Ghandahari, University of Utah

Co-Chair

Leonard F. Pease, University of Utah

Presentations

08:30 AM

(607a) Comparative Evaluation of Transitional Cell Carcinoma Treatments
W. T. Godbey, Xiujuan Zhang

08:50 AM

(607b) Formulation, Characterization and Evaluation of Curcumin-Loaded &gamma-Cyclodextrin Liposomal Nanoparticles On Osteosarcoma Cell Lines
Santosh S. Dhule, Patrice Penfornis, Trivia P. Frazier, Ryan W. Walker, Grace Tan, Jibao He, Radhika Pochampally, Vijay T. John

09:10 AM

(607c) Sustained, Targeted Intraocular Delivery of Therapeutics for the Treatment of Age-Related Macular Degeneration
Rangaramanujam M. Kannan, Bharath Raja Guru, Raymond Iezzi, Manoj K. Mishra

09:30 AM

(607d) Synthetic Zwitterlation of Enzymatic Proteins for Stability and Retained Enzymatic Kinetics
Andrew J. Keefe, Shaoyi Jiang

09:50 AM

(607e) Functionalized Alumina Particles for pH-Responsive Drug Delivery
Brad Gordon, Ezinne Achinivu, Douglas S. English, Daniel Lim, Charles E. Luckett, Sheryl H. Ehrman

10:10 AM

(607f) Cell Type-Dependent Uptake of PEGylated Nanoparticles
Kenny K. Tran, Hong Shen, Alyssa Sheih

10:30 AM

(607g) The Sound of Silence. Multiscale Molecular Simulations and Experiments in Developing Nanocarrier/Nucleic Acid Systems
Sabrina Pricl, Paola Posocco, Maurizio Fermeglia, Kostantinos Karatasos, Ling Peng, Dave K. Smith